Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antihypertensive Agents | 26 | 2012 | 391 | 3.130 |
Why?
|
| Hypertension | 44 | 2012 | 1264 | 2.900 |
Why?
|
| Tetrazoles | 9 | 2009 | 63 | 1.540 |
Why?
|
| Hydrochlorothiazide | 11 | 2011 | 68 | 1.330 |
Why?
|
| Valine | 6 | 2009 | 106 | 1.200 |
Why?
|
| Adrenergic alpha-Antagonists | 10 | 2001 | 46 | 0.930 |
Why?
|
| Fumarates | 4 | 2012 | 15 | 0.770 |
Why?
|
| Renin | 9 | 2012 | 89 | 0.770 |
Why?
|
| Amides | 4 | 2012 | 82 | 0.750 |
Why?
|
| Blood Pressure | 26 | 2012 | 1300 | 0.570 |
Why?
|
| Prostatic Hyperplasia | 4 | 2001 | 107 | 0.550 |
Why?
|
| Double-Blind Method | 26 | 2012 | 1561 | 0.550 |
Why?
|
| Prazosin | 9 | 1995 | 14 | 0.520 |
Why?
|
| Drug Therapy, Combination | 14 | 2012 | 1149 | 0.480 |
Why?
|
| Doxazosin | 8 | 2001 | 27 | 0.380 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 105 | 0.370 |
Why?
|
| Uncertainty | 1 | 2011 | 99 | 0.370 |
Why?
|
| Angiotensin II | 5 | 2000 | 161 | 0.360 |
Why?
|
| Fenoldopam | 2 | 1999 | 11 | 0.330 |
Why?
|
| Amlodipine | 3 | 2011 | 22 | 0.330 |
Why?
|
| Dopamine Agonists | 2 | 1999 | 79 | 0.320 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 6 | 1997 | 210 | 0.320 |
Why?
|
| Valsartan | 6 | 2009 | 21 | 0.310 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 1999 | 121 | 0.300 |
Why?
|
| Physicians | 2 | 2011 | 582 | 0.290 |
Why?
|
| Lovastatin | 5 | 1994 | 25 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2009 | 1685 | 0.290 |
Why?
|
| Middle Aged | 40 | 2012 | 25516 | 0.240 |
Why?
|
| Hypercholesterolemia | 5 | 1994 | 225 | 0.230 |
Why?
|
| Benzazepines | 2 | 2001 | 64 | 0.230 |
Why?
|
| Biphenyl Compounds | 2 | 2001 | 56 | 0.200 |
Why?
|
| Humans | 82 | 2012 | 121793 | 0.190 |
Why?
|
| Male | 47 | 2012 | 59243 | 0.190 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2001 | 17 | 0.180 |
Why?
|
| Losartan | 2 | 2012 | 33 | 0.170 |
Why?
|
| Enalapril | 4 | 1988 | 18 | 0.170 |
Why?
|
| Quinazolines | 1 | 2001 | 175 | 0.170 |
Why?
|
| Fosinopril | 2 | 1997 | 5 | 0.160 |
Why?
|
| Aged | 18 | 2008 | 18732 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2009 | 1022 | 0.160 |
Why?
|
| Calcium Channel Blockers | 3 | 2001 | 113 | 0.160 |
Why?
|
| Hemodynamics | 4 | 1999 | 840 | 0.160 |
Why?
|
| Heart Rate | 10 | 2012 | 583 | 0.160 |
Why?
|
| Coronary Disease | 4 | 2000 | 632 | 0.160 |
Why?
|
| Female | 38 | 2012 | 64573 | 0.150 |
Why?
|
| Clinical Trials as Topic | 9 | 2012 | 1078 | 0.150 |
Why?
|
| Lipids | 3 | 1991 | 504 | 0.140 |
Why?
|
| Adult | 32 | 2012 | 28549 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 1992 | 233 | 0.140 |
Why?
|
| Drug Combinations | 2 | 2009 | 263 | 0.140 |
Why?
|
| Triglycerides | 5 | 1994 | 547 | 0.130 |
Why?
|
| Cholesterol, LDL | 5 | 1994 | 548 | 0.130 |
Why?
|
| Pyrimidines | 1 | 1998 | 374 | 0.120 |
Why?
|
| Renin-Angiotensin System | 2 | 2012 | 95 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 1994 | 62 | 0.110 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 4 | 2009 | 51 | 0.110 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2012 | 4 | 0.100 |
Why?
|
| Treatment Outcome | 8 | 2011 | 12003 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2012 | 35 | 0.100 |
Why?
|
| Cholesterol | 3 | 1991 | 507 | 0.100 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 51 | 0.100 |
Why?
|
| Renal Artery | 2 | 1988 | 73 | 0.100 |
Why?
|
| Systole | 1 | 2011 | 197 | 0.090 |
Why?
|
| Diastole | 1 | 2011 | 170 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2011 | 242 | 0.090 |
Why?
|
| Vasodilation | 1 | 2012 | 191 | 0.090 |
Why?
|
| Diabetes Complications | 2 | 2003 | 194 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2011 | 384 | 0.090 |
Why?
|
| Proline | 1 | 1990 | 72 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 577 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 650 | 0.080 |
Why?
|
| Lipoproteins | 2 | 1991 | 175 | 0.080 |
Why?
|
| Diuretics | 4 | 1998 | 158 | 0.080 |
Why?
|
| Endothelium, Vascular | 2 | 2012 | 514 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 261 | 0.080 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 537 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2011 | 5960 | 0.070 |
Why?
|
| Intracranial Aneurysm | 6 | 1976 | 93 | 0.070 |
Why?
|
| Hypokalemia | 1 | 2007 | 39 | 0.070 |
Why?
|
| Minor Histocompatibility Loci | 1 | 2006 | 3 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2006 | 35 | 0.070 |
Why?
|
| Pan troglodytes | 1 | 2006 | 70 | 0.070 |
Why?
|
| Aortic Aneurysm | 1 | 1988 | 224 | 0.060 |
Why?
|
| Time Factors | 6 | 2008 | 6168 | 0.060 |
Why?
|
| Placebos | 4 | 1998 | 235 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2006 | 494 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 2809 | 0.060 |
Why?
|
| Aldosterone | 4 | 1999 | 59 | 0.060 |
Why?
|
| Cholesterol, HDL | 4 | 1994 | 336 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 638 | 0.060 |
Why?
|
| Verapamil | 2 | 1995 | 52 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2003 | 151 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2009 | 744 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 670 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2001 | 6275 | 0.050 |
Why?
|
| Kidney | 2 | 1988 | 1343 | 0.050 |
Why?
|
| Posture | 3 | 1999 | 152 | 0.050 |
Why?
|
| Neurosurgery | 3 | 1976 | 77 | 0.050 |
Why?
|
| Half-Life | 3 | 1999 | 157 | 0.050 |
Why?
|
| Alleles | 1 | 2006 | 1585 | 0.050 |
Why?
|
| Propranolol | 3 | 1991 | 127 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2003 | 232 | 0.050 |
Why?
|
| Prodrugs | 1 | 2001 | 59 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 2001 | 128 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 139 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2001 | 141 | 0.040 |
Why?
|
| Autonomic Nervous System Diseases | 3 | 1989 | 42 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 3 | 1976 | 563 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2008 | 1800 | 0.040 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 1998 | 34 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 1998 | 266 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 1999 | 231 | 0.040 |
Why?
|
| Craniotomy | 3 | 1972 | 108 | 0.040 |
Why?
|
| Mitral Valve Prolapse | 2 | 1989 | 28 | 0.040 |
Why?
|
| Lisinopril | 2 | 1988 | 25 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 1999 | 4953 | 0.040 |
Why?
|
| Creatine Kinase | 2 | 1994 | 54 | 0.040 |
Why?
|
| Obesity | 1 | 2008 | 1938 | 0.040 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1997 | 71 | 0.030 |
Why?
|
| Neurosurgical Procedures | 4 | 1963 | 296 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 1994 | 155 | 0.030 |
Why?
|
| Muscular Diseases | 2 | 1994 | 103 | 0.030 |
Why?
|
| Sympatholytics | 1 | 1996 | 4 | 0.030 |
Why?
|
| Oligopeptides | 2 | 2006 | 119 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2000 | 479 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 1976 | 36 | 0.030 |
Why?
|
| Adolescent | 5 | 1999 | 18773 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 837 | 0.030 |
Why?
|
| Animals | 4 | 2007 | 33870 | 0.030 |
Why?
|
| Life Tables | 1 | 1994 | 28 | 0.030 |
Why?
|
| Pilot Projects | 1 | 1999 | 1365 | 0.030 |
Why?
|
| Drug Evaluation | 2 | 1992 | 111 | 0.030 |
Why?
|
| Receptors, Adrenergic | 1 | 1994 | 29 | 0.030 |
Why?
|
| Models, Statistical | 1 | 1997 | 446 | 0.030 |
Why?
|
| Patient Selection | 1 | 1997 | 676 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 137 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1994 | 107 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1994 | 239 | 0.030 |
Why?
|
| Methyclothiazide | 1 | 1992 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 1997 | 649 | 0.030 |
Why?
|
| Norepinephrine | 5 | 1989 | 174 | 0.030 |
Why?
|
| Spinal Cord Neoplasms | 3 | 1963 | 68 | 0.020 |
Why?
|
| Risk Factors | 3 | 2008 | 9718 | 0.020 |
Why?
|
| Anterior Cerebral Artery | 2 | 1962 | 8 | 0.020 |
Why?
|
| Nicardipine | 1 | 1991 | 18 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1994 | 354 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1992 | 252 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2011 | 38 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2009 | 15794 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 279 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 1 | 1990 | 57 | 0.020 |
Why?
|
| Isoproterenol | 2 | 1989 | 105 | 0.020 |
Why?
|
| Headache | 1 | 2011 | 107 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 1990 | 90 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 374 | 0.020 |
Why?
|
| Osteoma | 2 | 1962 | 4 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 1994 | 629 | 0.020 |
Why?
|
| Endarterectomy | 1 | 1988 | 22 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1987 | 1103 | 0.020 |
Why?
|
| Diarrhea | 1 | 2011 | 319 | 0.020 |
Why?
|
| Cerebral Arterial Diseases | 1 | 1968 | 5 | 0.020 |
Why?
|
| United States | 3 | 1994 | 10413 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 1968 | 1165 | 0.020 |
Why?
|
| Carotid Sinus | 1 | 1987 | 5 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1968 | 56 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 1988 | 120 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 1988 | 189 | 0.020 |
Why?
|
| Neoplasms | 5 | 1963 | 2697 | 0.020 |
Why?
|
| Denervation | 1 | 1987 | 29 | 0.020 |
Why?
|
| Brain Stem | 1 | 1968 | 118 | 0.020 |
Why?
|
| Pheochromocytoma | 1 | 1987 | 33 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1990 | 872 | 0.020 |
Why?
|
| Astrocytoma | 1 | 1968 | 99 | 0.020 |
Why?
|
| Aneurysm | 1 | 1988 | 89 | 0.020 |
Why?
|
| Liver | 1 | 1994 | 1855 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1987 | 65 | 0.020 |
Why?
|
| Captopril | 1 | 1986 | 28 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1987 | 58 | 0.020 |
Why?
|
| Incidence | 2 | 2011 | 2962 | 0.020 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1966 | 6 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 1987 | 147 | 0.020 |
Why?
|
| Facial Paralysis | 1 | 1966 | 37 | 0.020 |
Why?
|
| Microscopy | 1 | 1966 | 119 | 0.020 |
Why?
|
| Neurilemmoma | 1 | 1966 | 44 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 293 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 551 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2008 | 439 | 0.020 |
Why?
|
| Paraplegia | 3 | 1975 | 91 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 423 | 0.020 |
Why?
|
| Kinetics | 3 | 1986 | 1316 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1994 | 4623 | 0.020 |
Why?
|
| Pyridines | 1 | 1986 | 222 | 0.020 |
Why?
|
| Dogs | 1 | 2006 | 769 | 0.020 |
Why?
|
| Dipeptides | 1 | 1985 | 56 | 0.020 |
Why?
|
| Brain | 3 | 1966 | 2941 | 0.010 |
Why?
|
| Homozygote | 1 | 2006 | 533 | 0.010 |
Why?
|
| Ataxia | 1 | 1966 | 168 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1988 | 524 | 0.010 |
Why?
|
| Heterozygote | 1 | 2006 | 679 | 0.010 |
Why?
|
| Foramen Magnum | 1 | 1963 | 5 | 0.010 |
Why?
|
| Pathology | 1 | 1963 | 41 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 1022 | 0.010 |
Why?
|
| Geriatrics | 1 | 1963 | 72 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 542 | 0.010 |
Why?
|
| Dopamine | 1 | 1984 | 272 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 1984 | 0.010 |
Why?
|
| Mucocele | 1 | 1962 | 9 | 0.010 |
Why?
|
| Frontal Sinus | 1 | 1962 | 11 | 0.010 |
Why?
|
| Meningioma | 1 | 1963 | 110 | 0.010 |
Why?
|
| Paranasal Sinuses | 1 | 1962 | 20 | 0.010 |
Why?
|
| Aneurysm, Ruptured | 1 | 1962 | 36 | 0.010 |
Why?
|
| Cochlear Nerve | 1 | 1961 | 11 | 0.010 |
Why?
|
| Cerebrum | 1 | 1962 | 32 | 0.010 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1961 | 7 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2700 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1963 | 173 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 3117 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 1962 | 47 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1961 | 29 | 0.010 |
Why?
|
| Quality of Life | 1 | 1991 | 1898 | 0.010 |
Why?
|
| Radiography | 1 | 1963 | 805 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1962 | 117 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3886 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 1961 | 57 | 0.010 |
Why?
|
| Edema | 1 | 2001 | 133 | 0.010 |
Why?
|
| Dietary Fats | 2 | 1991 | 273 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 3659 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 2926 | 0.010 |
Why?
|
| Hydroxylation | 1 | 1979 | 45 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1979 | 339 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 2997 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 1991 | 1227 | 0.010 |
Why?
|
| Hypothermia | 1 | 1958 | 51 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 473 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1979 | 968 | 0.010 |
Why?
|
| Epinephrine | 2 | 1989 | 174 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1958 | 146 | 0.010 |
Why?
|
| Lidoflazine | 1 | 1976 | 1 | 0.010 |
Why?
|
| Sweating | 1 | 1956 | 6 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1987 | 3441 | 0.010 |
Why?
|
| Hyperhidrosis | 1 | 1956 | 9 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 1956 | 66 | 0.010 |
Why?
|
| Information Systems | 1 | 1975 | 35 | 0.010 |
Why?
|
| Spine | 1 | 1956 | 146 | 0.010 |
Why?
|
| Renal Circulation | 2 | 1985 | 45 | 0.010 |
Why?
|
| Spinal Cord | 2 | 1946 | 302 | 0.010 |
Why?
|
| Piperazines | 1 | 1976 | 226 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1958 | 457 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 1954 | 445 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1975 | 384 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1958 | 479 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 1975 | 187 | 0.010 |
Why?
|
| Heart Failure | 1 | 1985 | 2125 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 149 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1972 | 79 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1991 | 76 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 1991 | 33 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 728 | 0.010 |
Why?
|
| Sodium | 2 | 1984 | 290 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1972 | 290 | 0.010 |
Why?
|
| Immersion | 1 | 1989 | 8 | 0.010 |
Why?
|
| Valsalva Maneuver | 1 | 1989 | 10 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1968 | 151 | 0.000 |
Why?
|
| Diagnosis, Differential | 2 | 1977 | 1868 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1968 | 102 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1976 | 996 | 0.000 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1987 | 7 | 0.000 |
Why?
|
| Carotid Arteries | 1 | 1968 | 151 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1991 | 335 | 0.000 |
Why?
|
| Vagus Nerve | 1 | 1987 | 43 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1991 | 369 | 0.000 |
Why?
|
| Hypothermia, Induced | 1 | 1968 | 158 | 0.000 |
Why?
|
| Isradipine | 1 | 1986 | 7 | 0.000 |
Why?
|
| Dextrans | 1 | 1967 | 45 | 0.000 |
Why?
|
| Teprotide | 1 | 1986 | 1 | 0.000 |
Why?
|
| Angiotensin I | 1 | 1986 | 10 | 0.000 |
Why?
|
| Peripheral Nerves | 1 | 1946 | 83 | 0.000 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1986 | 53 | 0.000 |
Why?
|
| Spinal Nerves | 1 | 1946 | 6 | 0.000 |
Why?
|
| Syringomyelia | 1 | 1946 | 17 | 0.000 |
Why?
|
| Neuralgia | 1 | 1946 | 44 | 0.000 |
Why?
|
| Spasm | 1 | 1946 | 48 | 0.000 |
Why?
|
| Paralysis | 1 | 1946 | 35 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1986 | 191 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 415 | 0.000 |
Why?
|
| Tracheotomy | 1 | 1966 | 35 | 0.000 |
Why?
|
| Enalaprilat | 1 | 1985 | 2 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1967 | 274 | 0.000 |
Why?
|
| Ependymoma | 1 | 1946 | 129 | 0.000 |
Why?
|
| Indocyanine Green | 1 | 1985 | 58 | 0.000 |
Why?
|
| Syndrome | 1 | 1987 | 1110 | 0.000 |
Why?
|
| Eating | 1 | 1986 | 349 | 0.000 |
Why?
|
| Neutrophils | 1 | 1987 | 371 | 0.000 |
Why?
|
| Metoclopramide | 1 | 1984 | 10 | 0.000 |
Why?
|
| Binding Sites | 1 | 1986 | 1294 | 0.000 |
Why?
|
| Pain | 1 | 1946 | 440 | 0.000 |
Why?
|
| Action Potentials | 1 | 1946 | 499 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1991 | 3601 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1972 | 2389 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1988 | 2031 | 0.000 |
Why?
|
| Furosemide | 1 | 1978 | 36 | 0.000 |
Why?
|
| Cardiac Conduction System Disease | 1 | 1958 | 7 | 0.000 |
Why?
|
| Brugada Syndrome | 1 | 1958 | 9 | 0.000 |
Why?
|
| Triamterene | 1 | 1977 | 1 | 0.000 |
Why?
|
| Benzothiadiazines | 1 | 1977 | 6 | 0.000 |
Why?
|
| Hyperaldosteronism | 1 | 1977 | 15 | 0.000 |
Why?
|
| Spironolactone | 1 | 1977 | 18 | 0.000 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1977 | 29 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1976 | 75 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1966 | 2987 | 0.000 |
Why?
|
| Motor Cortex | 1 | 1952 | 75 | 0.000 |
Why?
|
| Child | 1 | 1968 | 23789 | 0.000 |
Why?
|
| Cats | 1 | 1967 | 115 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1967 | 433 | 0.000 |
Why?
|